Clostridioides difficile Infection (CDI)
Prevalence: 500,000 infections/year in the US; 29,000 deaths
Evidence-Ranked Ingredients
| Ingredient | Grade | Studies | Direction | |
|---|---|---|---|---|
| Saccharomyces boulardii | B | 6 | Positive | View → |
About
A toxin-mediated colonic infection caused by C. difficile, typically following antibiotic-induced gut dysbiosis. Toxins A and B cause mucosal inflammation, fluid secretion, and pseudomembrane formation. Recurrence rate is 20-30% after first episode, rising to 40-65% after multiple episodes.
Common Symptoms
Risk Factors
- Recent antibiotic use
- Hospitalization
- Age >65
- PPI use
- Immunosuppression
- Prior CDI episode
- IBD
Frequently Asked Questions
What supplements may help with Clostridioides difficile Infection (CDI)?
How is the evidence for Clostridioides difficile Infection (CDI) supplements graded?
How many studies on Clostridioides difficile Infection (CDI) supplements have been reviewed?
What are common symptoms of Clostridioides difficile Infection (CDI)?
Related Conditions
Conditions that share studied ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.